Skip to content
★ Sign in to follow
RK

Ronald K. Lloyd

Executive
Chairman & CEO
Aziyo Biologics, Inc.Mallinckrodt plc
Total declarations
12
Companies
2
▲ Purchases (3 ops.)
€268k
▼ Sales (0 ops.)
—

Latest filing published 10 Mar 2022 for Aziyo Biologics, INC..

Insider track record

Disclosed buys
3
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Ronald K. Lloyd: trading record in brief

Ronald K. Lloyd is a declared insider at 2 companies (chief executive); the most frequent names are Mallinckrodt plc and Elutia Inc. We count 12 filings; the first trade dates from 4 January 2016 and the latest from 8 March 2022.

No open-market sale appears; the market trades are 3 purchases worth €268k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants and 1 option exercise.

The median purchase comes to €69k. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 10 March 2022, reports an option exercise in Elutia Inc. The clock since the last published purchase (11 May 2021) now reads 2,008 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Ronald K. Lloyd

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total

2 of 2 declarations